Table 3.
Treatment as received effects by history of PCI
| No Prior PCI | Prior PCI | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | MED | CABG | Unadjusted HR (95% CI) | Adjusted* HR (95% CI) | MED | CABG | Unadjusted HR (95% CI) | Adjusted* HR (95% CI) | Unadjusted Interaction p-value |
Adjusted* Interaction p-value |
| All-cause mortality | 350 (70.1%) | 314 (58.7%) | 0.76 (0.65, 0.88) | 0.75 (0.64, 0.88) | 52 (67.1%) | 41 (53.3%) | 0.65 (0.43, 0.98) | 0.63 (0.41, 0.95) | 0.500 | 0.414 |
| Cardiovascular mortality | 270 (59.2%) | 214 (43.1%) | 0.68 (0.57, 0.82) | 0.67 (0.56, 0.81) | 36 (52.5%) | 24 (36.2%) | 0.57 (0.34, 0.95) | 0.58 (0.34, 0.97) | 0.502 | 0.581 |
| All-cause mortality or CV hospitalization | 439 (87.6%) | 417 (79.6%) | 0.80 (0.70, 0.92) | 0.81 (0.70, 0.93) | 73 (100%) | 62 (80.5%) | 0.64 (0.45, 0.89) | 0.67 (0.47, 0.94) | 0.211 | 0.305 |
| CV hospitalization | 263 (67.6%) | 254 (61.1%) | 0.83 (0.70, 0.99) | 0.86 (0.72, 1.02) | 56 (100%) | 48 (69.8%) | 0.66 (0.45, 0.97) | 0.72 (0.48, 1.06) | 0.283 | 0.413 |
*
Models are adjusted for baseline age, sex, region, creatinine clearance, prior CABG, diseased vessels, heart rate, NYHA class, AF, MR, ESVI, diabetes, stroke, current smoking, chronic renal insufficiency, depression, and ACE/ARB use.